No­var­tis’ star can­cer drug lands on an in­side FDA track, rac­ing Lil­ly to a show­down with Pfiz­er

No­var­tis just got a help­ing hand from the FDA as it races against Eli Lil­ly to jump in­to a three-way tug of war with Pfiz­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.